scispace - formally typeset
Open AccessJournal ArticleDOI

A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease

TLDR
Current practices in the management of GD diverge in some areas from recently published guidelines; these differences should be assessed serially to determine the impact of the guidelines on future clinical practice.
Abstract
Context: More than two decades have passed since members from the American Thyroid Association (ATA), European Thyroid Association, and Japan Thyroid Association were surveyed on management practices for patients with hyperthyroidism due to Graves' disease (GD). Objective: We sought to document current practices in the management of GD and compare these results both to those documented in earlier surveys and to practice recommendations made in the 2011 ATA/American Association of Clinical Endocrinologists (AACE) hyperthyroidism practice guidelines. Lastly, we sought to examine differences in GD management among international members of U.S.-based endocrine societies. Methods: Members of The Endocrine Society (TES), ATA, and AACE were invited to participate in a web-based survey dealing with testing, treatment preference, and modulating factors in patients with GD. Results: A total of 730 respondents participated in the survey, 696 of whom completed all sections. Respondents included 641 TES members, 330 A...

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

TL;DR: If a patient relapses after completing a course of ATD, definitive treatment is recommended; however, continued long-term low-dose MMI can be considered, and steroid prophylaxis is warranted in Graves’ patients with mild/active orbitopathy receiving RAI.
Journal ArticleDOI

Management of Graves Disease: A Review

TL;DR: Management of Graves disease includes treatment with antithyroid drugs, RAI, or thyroidectomy, and Physicians should be familiar with the advantages and disadvantages of each therapy to best counsel their patients.
Journal ArticleDOI

Hyperthyroidism in pregnancy

TL;DR: Physiological and pathophysiological changes in thyroid hormone economy in pregnancy, the diagnosis and management of hyperthyroidism during pregnancy, severe life-threatening thyrotoxicosis inregnancy, neonatal thy rotoxicosis, and post-partum hyperthy thyroiditis are discussed.
References
More filters
Journal ArticleDOI

The spectrum of thyroid disease in a community: the whickham survey

TL;DR: TSH levels above 6 mu/1 were shown to reflect a significant lowering of circulating thyroxine levels and showed a strong association with thyroid antibodies in both sexes, independent of age.
Journal ArticleDOI

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

TL;DR: Radioiodine therapy for Graves' hyperthyroidism is followed by the appearance or worsening of ophthalmopathy more often than is therapy with methimazole, and this can be prevented by the administration of prednisone.
Journal ArticleDOI

Pathogenesis of Graves' ophthalmopathy.

TL;DR: Once initiated, the orbital immune process frequently takes on a momentum of its own, leading to non-specific but nonetheless harmful consequences such as tissue hypoxia, oxygen free radical damage and fibrogenic tissue remodeling.
Related Papers (5)